Value Bridge — LOYOLA UNIVERSITY MEDICAL CENTER
Current $-139M → Target $-108M (+$31.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-139.2M
Current EBITDA
$-108.2M
Target EBITDA
+$31.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.0M
Payer Mix Optimization
$16.8M
Cost to Collect Reduction
$5.6M
Clean Claim Improvement
$4.2M
Volume & Rate Growth
$28.1M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-139M to $-108M. The highest-impact lever is Volume & Rate Growth at $11.2M probability-weighted.
IC talking point: "We see $31M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $341M in equity value creation."